Log in

NASDAQ:CTHRCharles & Colvard, Ltd. Stock Price, Forecast & News

$0.70
+0.00 (+0.30 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.70
Now: $0.70
$0.73
50-Day Range
$0.67
MA: $0.73
$0.94
52-Week Range
$0.60
Now: $0.70
$1.66
Volume257,000 shs
Average Volume269,784 shs
Market Capitalization$20.35 million
P/E RatioN/A
Dividend YieldN/A
Beta0.33
Charles & Colvard, Ltd. manufactures, markets, and distributes moissanite jewels and finished jewelry featuring moissanite worldwide. The company offers near-colorless moissanite jewels cut in various shapes, including round, square brilliant, princess, cushion, radiant, pear, marquise, heart, and oval in sizes ranging from approximately 1.3 to 12 millimeters. It also provides finished jewelry featuring moissanite, such as stud earrings, solitaire and three-stone rings, pendants, and bracelets. The company primarily offers its products under the Charles & Colvard Created Moissanite, Forever Classic, Forever Brilliant, and Forever One brand names. It sells its products through distributors, manufacturers, retailers, television shopping networks, and designers, as well as at retail to end consumers through its direct-to-consumer e-commerce site, charlesandcolvard.com, third-party online marketplaces, drop-ship, and e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is based in Morrisville, North Carolina.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Jewelry, silverware, & plated ware
Sub-IndustryN/A
Current SymbolNASDAQ:CTHR
CUSIPN/A
Phone919-468-0399

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.24 million
Cash Flow$0.10 per share
Book Value$1.60 per share

Profitability

Net Income$2.27 million

Miscellaneous

Employees59
Market Cap$20.35 million
Next Earnings Date9/3/2020 (Estimated)
OptionableNot Optionable

Receive CTHR News and Ratings via Email

Sign-up to receive the latest news and ratings for CTHR and its competitors with MarketBeat's FREE daily newsletter.

Charles & Colvard, Ltd. (NASDAQ:CTHR) Frequently Asked Questions

How has Charles & Colvard, Ltd.'s stock been impacted by COVID-19 (Coronavirus)?

Charles & Colvard, Ltd.'s stock was trading at $0.7553 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CTHR shares have decreased by 7.0% and is now trading at $0.7022. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Charles & Colvard, Ltd.?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Charles & Colvard, Ltd..

When is Charles & Colvard, Ltd.'s next earnings date?

Charles & Colvard, Ltd. is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020. View our earnings forecast for Charles & Colvard, Ltd..

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) announced its quarterly earnings data on Thursday, May, 21st. The company reported ($0.03) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.01. The business had revenue of $6.49 million for the quarter, compared to analyst estimates of $6 million. Charles & Colvard, Ltd. had a negative net margin of 15.36% and a positive return on equity of 0.71%. View Charles & Colvard, Ltd.'s earnings history.

Has Charles & Colvard, Ltd. been receiving favorable news coverage?

Media coverage about CTHR stock has trended negative on Tuesday, InfoTrie reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Charles & Colvard, Ltd. earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Charles & Colvard, Ltd..

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 41,900 shares, an increase of 110.6% from the June 15th total of 19,900 shares. Based on an average daily volume of 264,200 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.2% of the company's shares are short sold. View Charles & Colvard, Ltd.'s Current Options Chain.

Who are some of Charles & Colvard, Ltd.'s key competitors?

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), Matinas BioPharma (MTNB), Pennsylvania R.E.I.T. (PEI), Unit (UNT), ADMA Biologics (ADMA), AMC Entertainment (AMC), DHT (DHT), Enerplus (ERF) and Gannett (GCI).

Who are Charles & Colvard, Ltd.'s key executives?

Charles & Colvard, Ltd.'s management team includes the following people:
  • Ms. Suzanne T. Miglucci, CEO, Pres & Director (Age 58)
  • Mr. Clint J. Pete, CFO & Treasurer (Age 57)
  • Mr. Don O'Connell, COO & Sr. VP of Supply Chain (Age 53)
  • Mr. John Lane, VP of Marketing
  • Mr. Randall N. McCullough, Advisory Consulting (Age 67)

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $0.70.

How big of a company is Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. has a market capitalization of $20.35 million and generates $32.24 million in revenue each year. The company earns $2.27 million in net income (profit) each year or $0.10 on an earnings per share basis. Charles & Colvard, Ltd. employs 59 workers across the globe.

What is Charles & Colvard, Ltd.'s official website?

The official website for Charles & Colvard, Ltd. is www.charlesandcolvard.com.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at 919-468-0399 or via email at [email protected]

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.